Role of autophagy in acute myeloid leukemia therapy

Chinese Journal of Cancer

Volumn 32, Issue 3, 2013, Pages 130-135

  Zhang, Su Ping ^a   Niu, Yu Na ^a   Yuan, Na ^a   Zhang, Ai Hong ^a   Chao, Dan ^a   Xu, Qiu Ping ^a   Wang, Li Jun ^a   Zhang, Xue Guang ^a   Zhao, Wen Li ^b   Zhao, Yun ^a   Wang, Jian Rong ^a  

^a SOOCHOW UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; Autophagy; Fusion oncoprotein

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; BECLIN 1; CALCITRIOL; CARBOPLATIN; CARNOSIC ACID; COLECALCIFEROL; DAPORINAD; DEXAMETHASONE; DOCETAXEL; EUPALININ A; FARNOQUINONE; HYBRID PROTEIN; MORPHINONE; ONCOPROTEIN; PACLITAXEL; PLATONIN; PML RAR PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; SEOCALCITOL; SESQUITERPENE LACTONE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; AUTOPHAGY; CANCER INHIBITION; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; HEMATOPOIETIC STEM CELL; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; LEUKEMIA REMISSION; LOW DRUG DOSE; MALIGNANT TRANSFORMATION; NONHUMAN; PROMYELOCYTIC LEUKEMIA; REVIEW;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MOLECULAR TARGETED THERAPY; ONCOGENE PROTEINS, FUSION; TRETINOIN;

EID: 84874873315     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.012.10073     Document Type: Review

References (64)

1. Colell A, Ricci JE, Tait S, et al. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell, 2007,129:983-997.
2. Iwata J, Ezaki J, Komatsu M, et al. Excess peroxisomes are degraded by autophagic machinery in mammals. J Biol Chem, 2006,281:4035-4041.
3. Mathew R, Kongara S, Beaudoin B, et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev, 2007,21:1367-1381.
4. Mathew R, Karp CM, Beaudoin B, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell,2009,137:1062-1075.
5. Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem, 2007,282:24131-24145.
6. Lum JJ, DeBerardinis RJ, Thompson CB. Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol, 2005,6:439-448.
7. Altman BJ, Wofford JA, Zhao Y, et al. Autophagy provides nutrients but can lead to chop-dependent induction of Bim to sensitize growth factor deprived cells to apoptosis. Mol Biol Cell, 2009,20:1180-1191.
8. Singh R, Kaushik S, Wang Y, et al. Autophagy regulates lipid metabolism. Nature, 2009,458:1131-1135.
9. Bursch W, Hochegger K, Torok L, et al. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J Cell Sci, 2000,113:1189-1198.
10. Inbal B, Bialik S, Sabanay I, et al. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J Cell Biol, 2002,157:455-468.
11. Paglin S, Hollister T, Delohery T, et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res, 2001,61:439-444.
12. Hoyer-H ansen M, Bastholm L, Mathiasen S, et al. Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin1-mediated autophagic cell death. Cell Death Differ, 2005,12:1297-1309.
13. Wang J, Lian H, Zhao Y, et al. Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem, 2008,283:25596-25605.
14. Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 1999,402:672-676.
15. Yue Z, Jin S, Yang C, et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA, 2003,100:15077-15082.
16. Degenhardt K, Mathew R, Beaudoin B, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell, 2006,10:51-64.
17. Jin S, White E. Role of autophagy in cancer: management of metabolic stress. Autophagy, 2007,3:28-31.
18. Karantza-Wadsworth V, Patel S, Kravchuk O, et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev, 2007,21:1621-1635.
19. Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer, 2003,3:89-101.
20. Jordan CT, Guzman ML. Mechanisms controlling pathogenesis and survival of leukemic stem cells. Oncogene, 2004,23:7178-7187.
21. Zheng X, Seshire A, Ruster B, et al. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARa-positive stem cells. Heamatologica, 2007,92:323-331.
22. Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 1988,72:567-572.
23. Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood, 1999,93:3167-3215.
24. Chen GQ, Zhu J, Shi XG, et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As 2O 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-R AR alpha/PML proteins. Blood, 1996,88: 1052-1061.
25. Chen GQ, Shi XG, Tang W, et al. Use of arsenic trioxide (As 2O 3) in the treatment of acute promyelocytic leukemia (APL):I. As 2O 3 exerts dose-dependent dual effects on APL cells. Blood, 1997,89:3345-3353.
26. Shen ZX, Chen GQ, Ni JH, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL):II.clinical efficacy and pharmacokinetics in relapsed patients. Blood, 1997,89:3354-3360.
27. Lallemand-B reitenbach V, Jeanne M, Benhenda S, et al. Arsenic degrades PML or PML-R ARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol, 2008,10:547-555.
28. Tatham MH, Geoffroy MC, Shen L, et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol, 2008,10:538-546.
29. Zhang XW, Yan XJ, Zhou ZR, et al. Arsenic trioxide controls the fate of the PML-R ARalpha oncoprotein by directly binding PML. Science, 2010,328:240-243.
30. Shen ZX, Shi ZZ, Fang J, et al. All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci USA, 2004,101:5328-5335.
31. Hu J, Liu YF, Wu CF, et al. Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci USA, 2009,106:3342-3347.
32. Shen TH, Lin HK, Scaglioni PP, et al. The mechanisms of PML-nuclear body formation. Mol Cell, 2006,24:331-339.
33. Bernardi R, Pandolfi PP. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol,2007,8:1006-1016.
34. Lamark T, Kirkin V, Dikic I, et al. NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle, 2009,8:1986-1990.
35. Isakson P, Bjoras M, Boe SO, et al. Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. Blood, 2010,116:2324-2331.
36. Song J, Qu Z, Guo X, et al. Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells. Autophagy, 2009,5:1131-1144.
37. Qian W, Liu J, Jin J, et al. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin1. Leuk Res, 2007,31:329-339.
38. Goussetis DJ, Altman JK, Glaser H, et al. Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide. J Biol Chem, 2010,285:29989-29997.
39. Nedelsky NB, Todd PK, Taylor JP. Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection. Biochim Biophys Acta, 2008,1782:691-699.
40. Wang Z, Cao L, Kang R, et al. Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARa oncoprotein. Autophagy, 2011,7:404-411.
41. Huang Y, Hou JK, Chen TT, et al. PML-RARa enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway. Autophagy, 2011,7:1132-1144.
42. Chen Z, Brand NJ, Chen A, et al. Fusion between a novel Kruppel-lik e zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t (11;17) translocation associated with acute promyelocytic leukaemia. EMBO J, 1993,12:1161-1167.
43. Licht JD, Chomienne C, Goy A, et al. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood, 1995,85:1083-1094.
44. Ruthardt M, Testa U, Nervi C, et al. Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RARalpha) and PLZF-R ARalpha fusion proteins on retinoic acid signaling. Mol Cell Biol, 1997,17:4859-4869.
45. Koken MH, Daniel MT, Gianni M, et al. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t (11;17) (q23;q21) APL patient. Oncogene, 1999,18:1113-1118.
46. Sternsdorf T, Puccetti E, Jensen K, et al. PIC-1/ SUMO-1-modified PML retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Mol Cell Biol, 1999,19:5170-5178.
47. Collins SJ. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia, 2002,16:1896-1905.
48. Bug G, Gul H, Schwarz K, et al. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res, 2005,65:2537-2541.
49. Trocoli A, Mathieu J, Priault M, et al. ATRA-induced upregulation of Beclin1 prolongs the life span of differentiated acute promyelocytic leukemia cells. Autophagy, 2011,7:1108-1114.
50. Yang L, Yang M, Zhang H, et al. S100A8-targeting siRNA enhances arsenic trioxide-induced myeloid leukemia cell death by down-regulating autophagy. Int J Mol Med, 2012,29:65-72.
51. Breitkreutz I, Raab MS, Vallet S, et al. Targeting MER1/2 blocks osteoclast differentiation function and cytokine secretion in multiple myeloma. Br J Haematol, 2007,139:55-63.
52. Capiati D A, Rossi AM, Picotto G, et al. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)-vitamin D3 in MCF-7 breast cancer cells. J Cell Biochem, 2004,93:384-397.
53. Wang J, Zhao Y, Kauss MA, et al. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling. Eur J Cell Biol, 2009,88:103-115.
54. Pepper C, Thomas A, Hoy T, et al. The vitamin D3 analog EB1089 induces apoptosis via p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood, 2003,101:2454-2460.
55. Beer TM, Eilers KM, Garzotto M, et al. Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. J Clin Oncol, 2003,21:128-138.
56. Beer TM, Ryan CW, Venner PM. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT investigators. J Clin Oncol, 2007,25:669-674.
57. Danilenko M, Wang X, Studzinski GP. Carnosic acid and promotion of monocytic differentiation of HL-60 cells initiated by other agents. J Natl Cancer Inst, 2001,93:1224-1233.
58. Yokoyama T, Miyazama K, Naito M, et al. Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells. Autophagy, 2008,4:629-640.
59. Itoh T, Ohguchi K, Nozawa Y, et al. Intracellular glutathione regulates sequiterpene lactone-in duced conversion of autophagy to apoptosis in human leumia HL-60 cells. Anticancer Res, 2009,29:1449-1457.
60. Fabre C, Carvalho G, Tasdemir E, et al. NF-B inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene, 2007,26:4071-4083.
61. Takeuchi R, Hoshijima H, Nagasaka H, et al. Induction of non-apoptotic cell death by morphinone in human promyclocytic leukemia HL-60 cells. Anticancer Res, 2006,26:3343-3348.
62. Nahimana A, Attingger A, Aubry D, et al. The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies. Blood, 2009,113:3276-3286.
63. Chen YJ, Huang WP, Yang YC, et al. Platonin induces autophagy-associated cell death in human leukemia cells. Autophagy, 2009,5:173-183.
64. Mortensen M, Watson AS, Simon AK. Lack of autophagy in the hematopoietic system leads to loss of hematopoietic stem cell function and dysregulated myeloid proliferation. Autophagy, 2011,7:1069-1070.